To update cancer mortality statistics in Italy, analyzing 1980-2010 trends, and to predict 2015 mortality rates.
Methods
World Health Organization cancer mortality and census data were extracted to calculate death rates for 30 cancer sites from 1980 to 2010. Trends were analyzed with joinpoint regression and predicted 2015 deaths rates were computed.
Results
In 2010 in Italy, there were 175,046 cancer deaths (98,847 men and 76,199 women), with total mortality rates, respectively, of 138.22 and 82.6/100,000. The leading cause of cancer death in men was lung cancer (25,457 deaths, 36.2/100,000), whereas in women it was breast cancer (12,115 deaths, 15.38/100,000). Total cancer mortality in men has been decreasing since the late 1980s, with an estimated annual percentage change (EAPC) of −1.8 in 1994-2010. In women, total cancer mortality rates decreased throughout the study period, with an EAPC of −1.1 in 1992-2010. Trends in mortality were decreasing for most cancers in both sexes. Only pancreatic and lung cancer trends in women were unfavorable. Total numbers of predicted cancer deaths in Italy for 2015 increased to 102,647 men and 82,047 women; however, the predicted rates decreased in men (129.1/100,000), while remaining stable in women (82.6/100,000).
Conclusions
Mortality rates for the most common cancers in Italy showed favorable trends that are likely to continue in the near future, with the exception of lung cancer mortality in women. Maintaining these trends requires continuous and improved control of tobacco, alcohol, and nutrition/overweight. Further improvements in diagnosis and treatment may also have a significant impact on cancer mortality.
Get full access to this article
View all access options for this article.
References
1.
ArfèAMalvezziMBertuccioPDecarliALa VecchiaCNegriECancer mortality trend analysis in Italy, 1970-2007. Eur J Cancer Prev2011;20 (5):364–374
2.
BosettiCBertuccioPMalvezziMCancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Ann Oncol2013;24 (10):2657–2671
3.
ChatenoudLBertuccioPBosettiCTrends in mortality from major cancers in the Americas: 1980-2010. Ann Oncol2014;25 (9):1843–1853
4.
RossoTMalvezziMBertuccioPNegriELa VecchiaCDecarliACancer mortality in Italy, 2008, and predictions for 2012. Tumori2012;98 (5):559–567
KimHJFayMPFeuerEJMidthuneDNPermutation tests for joinpoint regression with applications to cancer rates. Stat Med2000;19 (3):335–351
7.
MalvezziMBertuccioPRossoTEuropean cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women?Ann Oncol2015;26 (4):779–786
8.
European Commission. 2014. Eurostat population databaseAccessed 15 July 2014.
9.
MalvezziMBosettiCRossoTLung cancer mortality in European men: trends and predictions. Lung Cancer2013; 80 (2):138–145
10.
GallusSLugoAColomboPPacificiRLa VecchiaCSmoking prevalence in Italy 2011 and 2012, with a focus on hand-rolled cigarettes. Prev Med2013;56 (5):314–318
11.
BoffettaPBocciaSLa VecchiaCA quick guide to cancer epidemiology. SpringerBriefs in Cancer Research2014.
12.
La VecchiaCBosettiCBertuccioPCastroCPelucchiCNegriETrends in alcohol consumption in Europe and their impact on major alcohol-related cancers. Eur J Cancer Prev2014;23 (4): 319–322
13.
BoffettaPLa VecchiaCNeoplasms. In: DetelsR, BeagleholeR, LansangMA, GullifordM, eds. The Practice of Public Health. Oxford Textbook of Public HealthNew YorkOxford University Press2009:997-1020.
14.
BonifaziMMalvezziMBertuccioPAge-period-cohort analysis of oral cancer mortality in Europe: the end of an epidemic?Oral Oncol2011;47 (5):400–407
15.
MalvezziMBonifaziMBertuccioPAn age-period-cohort analysis of gastric cancer mortality from 1950 to 2007 in Europe. Ann Epidemiol2010;20 (12):898–905
16.
RougierPMitryEEpidemiology, treatment and chemoprevention in colorectal cancer. Ann Oncol2003;1490002 Suppl 2: ii3–ii5
17.
BoylePAutierPBartelinkHEuropean Code Against Cancer and scientific justification: third version (2003). Ann Oncol2003;14 (7):973–1005
18.
CibulaDGompelAMueckAOHormonal contraception and risk of cancer. Hum Reprod Update2010;16 (6):631–650
19.
BosettiCTuratiFLa VecchiaCHepatocellular carcinoma epidemiology. Best Pract Res Clin Gastroenterol2014;28 (5):753–770
20.
RandiGMalvezziMLeviFEpidemiology of biliary tract cancers: an update. Ann Oncol2009;20 (1):146–159
21.
HundalRShafferEAGallbladder cancer: epidemiology and outcome. Clin Epidemiol2014;6:99–109
22.
AsciuttoRLugoAGallusSRoncaglioniMCLa VecchiaCBosettiCPrevalence and determinants of diabetes mellitus in a representative sample of Italian adults. Epidemiology Biostatistics Public Health2014;11 (4):e99801–e99808
23.
LipworthLZucchettoABosettiCDiabetes mellitus, other medical conditions and pancreatic cancer: a case-control study. Diabetes Metab Res Rev2011;27 (3):255–261
MalvezziMBertuccioPLeviFLa VecchiaCNegriEEuropean cancer mortality predictions for the year 2014. Ann Oncol2014; 25 (8):1650–1656
26.
BoffettaPStaynerLPleural and peritoneal neoplasms. In: SchottenfeldD, FraumeniJFJr., eds. Cancer Epidemiology and PreventionNew YorkOxford University Press2006:659-673.
27.
PelucchiCMalvezziMLa VecchiaCLeviFDecarliANegriEThe mesothelioma epidemic in Western Europe: an update. Br J Cancer2004;90 (5):1022–1024
28.
GruberSBArmstrongBKCutaneous and ocular melanoma. In: SchottenfeldD, FraumeniJFJr., eds. Cancer Epidemiology and PreventionNew YorkOxford University Press2006:1196-1229.
29.
AutierPBoniolMLa VecchiaCDisparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ2010; 341:c3620
30.
BosettiCBertuccioPLeviFChatenoudLNegriELa VecchiaCThe decline in breast cancer mortality in Europe: an update (to 2009). Breast2012;21 (1):77–82
31.
JatoiIMillerABWhy is breast-cancer mortality declining?Lancet Oncol2003;4 (4):251–254
32.
La VecchiaCBosettiCLucchiniFCancer mortality in Europe, 2000-2004, and an overview of trends since 1975. Ann Oncol2010;21 (6):1323–1360
33.
ElfströmKMArnheim-DahlströmLvon KarsaLDillnerJCervical cancer screening in Europe: quality assurance and organisation of programmes. Eur J Cancer2015;51 (8):950–968
34.
WeiderpassEAntoineJBrayFIOhJKArbynMTrends in corpus uteri cancer mortality in member states of the European Union. Eur J Cancer2014;50 (9):1675–1684
35.
La VecchiaCDecarliAFasoliMOral contraceptives and cancers of the breast and of the female genital tract. Interim results from a case-control study. Br J Cancer1986;54 (2): 311–317
36.
EtzioniRGulatiRTsodikovAThe prostate cancer conundrum revisited: treatment changes and prostate cancer mortality declines. Cancer2012;118 (23):5955–5963
37.
BosettiCBertuccioPChatenoudLNegriELa VecchiaCLeviFTrends in mortality from urologic cancers in Europe, 1970-2008. Eur Urol2011;60 (1):1–15
38.
SchröderFHHugossonJRoobolMJet al;ERSPC Investigators. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med2009;360 (13):1320–1328
39.
CuzickJThoratMAAndrioleGPrevention and early detection of prostate cancer. Lancet Oncol2014;15 (11):e484–e492
40.
PelucchiCBosettiCNegriEMalvezziMLa VecchiaCMechanisms of disease: the epidemiology of bladder cancer. Nat Clin Pract Urol2006;3 (6):327–340
41.
ChowWHDongLMDevesaSSEpidemiology and risk factors for kidney cancer. Nat Rev Urol2010;7 (5):245–257
42.
La VecchiaCMalvezziMBosettiCThyroid cancer mortality and incidence: a global overview. Int J Cancer2015; 136 (9): 2187–2195
43.
BosettiCLeviFFerlayJLucchiniFNegriELa VecchiaCThe recent decline in mortality from Hodgkin lymphomas in central and eastern Europe. Ann Oncol2009;20 (4):767–774
BosettiCLeviFFerlayJLucchiniFNegriELa VecchiaCIncidence and mortality from non-Hodgkin lymphoma in Europe: the end of an epidemic?Int J Cancer2008;123 (8):1917–1923
46.
BertuccioPBosettiCMalvezziMTrends in mortality from leukemia in Europe: an update to 2009 and a projection to 2012. Int J Cancer2013;132 (2):427–436
47.
MalvezziMBertuccioPChatenoudLNegriELa VecchiaCDecarliACancer mortality in Italy, 2003. Tumori2009;95 (6):655–664
48.
Lortet-TieulentJRenteriaESharpLConvergence of decreasing male and increasing female incidence rates in major tobacco-related cancers in Europe in 1988-2010. Eur J CancerEpub 2013 Nov 20.
49.
PirieKPetoRReevesGKGreenJBeralVMillion Women Study Collaborators. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet2013;381 (9861):133–141
50.
De AngelisRSantMColemanMPet al;EUROCARE-5 Working Group. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE-5: a population-based study. Lancet Oncol2014;15 (1):23–34
